Medical Journal of Australia
Volume 190, Issue 12, 2009, Pages 670-673

Chronic hepatitis B and C infection in children in New South Wales (Article)

Nightingale S.* , Stormon M.O. , Day A.S. , Webber M.T. , Ward K.A. , O'Loughlin E.V.
  • a Department of Gastroenterology, Children's Hospital at Westmead, Sydney, NSW, Australia
  • b Department of Gastroenterology, Children's Hospital at Westmead, Sydney, NSW, Australia
  • c Department of Gastroenterology, Sydney Children's Hospital, Sydney, NSW, Australia, School of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia
  • d Hunter New England Area Health Service, Newcastle, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia
  • e Communicable Diseases Branch, NSW Health, Sydney, NSW, Australia
  • f Department of Gastroenterology, Children's Hospital at Westmead, Sydney, NSW, Australia

Abstract

Objective: To characterise epidemiological, clinical and laboratory features of children in New South Wales with chronic hepatitis B (HBV) or C (HCV) infections. Design and setting: Retrospective record review of epidemiological, clinical, laboratory, liver biopsy and treatment data for children (aged < 18 years) referred to tertiary referral paediatric and refugee clinics in NSW with chronic HBV or HCV during 2000-2007; and comparison with NSW Health notification data for the same period. Main outcome measures: Numbers and characteristics of referred children with HBV and HCV, and notifications to NSW Health. Results: During 2000-2007, 79 children with chronic HBV and 29 with HCV infection were referred to specialist clinics, while 930 children with HBV and 777 with HCV infection were reported to NSW Health. Most of the referred children with HBV were born overseas, while most with HCV were born in Australia to mothers with a history of intravenous drug use. Of the 79 HBV-infected children, 56 were e-antigen positive. Most HCV-infected children (23/29) had alanine aminotransferase levels ≤2 times the upper limit of normal, and more than half of those who had genotype determined had type 2 or 3. Fibrosis was evident in liver biopsies performed for both HBV and HCV. Conclusions: Although advanced liver disease was uncommon in children referred with HBV or HCV infection, a large number of infected children in NSW were not referred for specialist medical care, indicating that opportunities to intervene early in the natural history of these infections, particularly HCV, are being missed.

Author Keywords

[No Keywords available]

Index Keywords

genetics genotype medical record review differential diagnosis Diagnosis, Differential multicenter study alanine aminotransferase blood level Human immunodeficiency virus infection Australia clinical trial alanine aminotransferase seroconversion Follow-Up Studies follow up clinical feature human birthplace health service controlled study comparative study pathology Hepatitis C virus Hepatitis C, Chronic morbidity pediatric hospital Hepatitis B virus prognosis RNA, Viral biopsy laboratory test Humans school child human tissue liver fibrosis Adolescent virology male female patient referral Infant Liver Child, Preschool liver biopsy preschool child virus RNA New South Wales immunology polymerase chain reaction isolation and purification Article Retrospective Studies hepatitis B antigen hepatitis C antigen major clinical study mother Hepatitis B, Chronic Hepatitis C Antigens serology Hepatitis B Antigens United Kingdom medical specialist hepatitis C antibody retrospective study hepatitis B intravenous drug abuse Hepacivirus public health hepatitis C Child

Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-68349121645&partnerID=40&md5=af61c6561c110a2cdf0e9280f75db0af

ISSN: 0025729X
Cited by: 7
Original Language: English